Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2014

Nov 21, 2014

30071_dirs_2014-11-21_9d7e45a5-a54c-434a-b2f2-6c719f0987c1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2014-11-19

Reporting Person: WAREHAM JOHN P (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-11-19 ResMed Common Stock Options $52.02 A 23629 Acquired 2021-11-19 ResMed Commmon Stock (23629) Direct

Holdings (Non-Derivative)

Security Shares Ownership
ResMed Common Stock 13000 Direct

Footnotes

F1: Options vest in full (i) on the first Nov. 11 following the grant date or (ii) the first annual shareholder's meeting following grant date. Options have a required holding period until the earlier of (i) Nov. 11 of the third year following grant date or (ii) six months following termination of directorship.